Recombinant LCN2 significantly promoted the phosphorylation levels of JAK2 and STAT3, but not of JAK1 and Tyk2, and increased CXCL1 levels in PAAD cells (Fig. 6c, Supplementary Fig. 20). This evidence concerns the gene JAK2 and pancreatic adenocarcinoma.